Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12446737rdf:typepubmed:Citationlld:pubmed
pubmed-article:12446737lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12446737lifeskim:mentionsumls-concept:C0007603lld:lifeskim
pubmed-article:12446737lifeskim:mentionsumls-concept:C0002812lld:lifeskim
pubmed-article:12446737lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:12446737lifeskim:mentionsumls-concept:C1420193lld:lifeskim
pubmed-article:12446737lifeskim:mentionsumls-concept:C0003075lld:lifeskim
pubmed-article:12446737lifeskim:mentionsumls-concept:C1621574lld:lifeskim
pubmed-article:12446737lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:12446737lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:12446737lifeskim:mentionsumls-concept:C1707271lld:lifeskim
pubmed-article:12446737pubmed:issue5lld:pubmed
pubmed-article:12446737pubmed:dateCreated2003-1-28lld:pubmed
pubmed-article:12446737pubmed:abstractTextHuman AE1 performs electroneutral exchange of Cl(-) for HCO(3)(-) across the erythrocyte membrane. We examined the topology of the AE1 C-terminal region using cysteine-scanning mutagenesis and sulfhydryl-specific chemistry. Eighty individual cysteine residues, introduced into an otherwise cysteine-less mutant between Phe(806) and Cys(885), were expressed by transient transfection of HEK293 cells. Topology of the region was determined by comparing cysteine labeling with the membrane-permeant cysteine-directed reagent biotin maleimide, with or without prior labeling with the membrane-impermeant reagents, bromotrimethylammoniumbimane bromide (qBBr) and lucifer yellow iodoacetamide (LYIA). Phe(806)-Leu(835), Ser(852)-Ala(855), and Ile(872)-Cys(885) were labeled by biotin maleimide, suggesting their location in an aqueous environment. In contrast, Phe(836)-Lys(851) and Ser(856)-Arg(871) were not labeled by biotin maleimide and therefore localize to the plane of the bilayer, as transmembrane segments (TM). Labeling by qBBr revealed that Pro(815)-Lys(829) and Ser(852)-Ala(855) are accessible to the extracellular medium. Pro(815)-Lys(829) mutants were also labeled with LYIA. Mutants Ile(872)-Cys(885) were inaccessible to the extracellular medium and thus localized to the intracellular surface of AE1. Functional assays revealed that one face of each of two AE1 TMs was sensitive to mutation. Based on these results, we propose a topology model for the C-terminal region of the membrane domain of human AE1.lld:pubmed
pubmed-article:12446737pubmed:languageenglld:pubmed
pubmed-article:12446737pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12446737pubmed:citationSubsetIMlld:pubmed
pubmed-article:12446737pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12446737pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12446737pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12446737pubmed:statusMEDLINElld:pubmed
pubmed-article:12446737pubmed:monthJanlld:pubmed
pubmed-article:12446737pubmed:issn0021-9258lld:pubmed
pubmed-article:12446737pubmed:authorpubmed-author:CaseyJoseph...lld:pubmed
pubmed-article:12446737pubmed:authorpubmed-author:ZhuQuanshengQlld:pubmed
pubmed-article:12446737pubmed:authorpubmed-author:LeeDiana W...lld:pubmed
pubmed-article:12446737pubmed:issnTypePrintlld:pubmed
pubmed-article:12446737pubmed:day31lld:pubmed
pubmed-article:12446737pubmed:volume278lld:pubmed
pubmed-article:12446737pubmed:ownerNLMlld:pubmed
pubmed-article:12446737pubmed:authorsCompleteYlld:pubmed
pubmed-article:12446737pubmed:pagination3112-20lld:pubmed
pubmed-article:12446737pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:meshHeadingpubmed-meshheading:12446737...lld:pubmed
pubmed-article:12446737pubmed:year2003lld:pubmed
pubmed-article:12446737pubmed:articleTitleNovel topology in C-terminal region of the human plasma membrane anion exchanger, AE1.lld:pubmed
pubmed-article:12446737pubmed:affiliationCanadian Institutes of Health Research Membrane Protein Research Group, Department of Physiology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.lld:pubmed
pubmed-article:12446737pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12446737pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:6521entrezgene:pubmedpubmed-article:12446737lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12446737lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12446737lld:pubmed